Last $181.96 USD
Change Today +3.09 / 1.73%
Volume 433.8K
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitleKey Developments
R. Norby 53 RelationshipsLead Independent Director, Chairman of Audit Committee, Chairman of Risk Committee and Member of Nominating & Corporate Governance Committee 
Andreas Rummelt Ph.D. 23 RelationshipsDirector, Chairman of Pharmaceutical Compliance & Quality Committee, Member of Audit Committee and Member of Risk Committee 

Compensation Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitle
William Keller 42 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk Committee
Alvin Parven 10 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Ann Veneman J.D. 52 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk Committee
ALXN Compensation vs. Industry
1.2M
361.7K
Chief Executive Officer
615.0K
265.9K
Chief Financial Officer
Share price activity for ALEXION PHARMACEUTICALS INC (ALXN)
52 Week Price Performance
ALXN
Industry Average

Nominating Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitleKey Developments
R. Norby 53 RelationshipsLead Independent Director, Chairman of Audit Committee, Chairman of Risk Committee and Member of Nominating & Corporate Governance CommitteeAlexion Pharmaceuticals, Inc. Announces Board Changes, Effective from January 1, 2015
11/10/14
Alvin Parven 10 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance CommitteeAlexion Pharmaceuticals, Inc. Announces Executive Appointments
10/9/14
William Keller 42 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk CommitteeAlexion Pharmaceuticals, Inc. Announces Passing of Max Link, Chairman of Board of Directors
10/7/14
Ann Veneman J.D. 52 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk CommitteeAlexion Pharmaceuticals, Inc. Announces Executive Appointments
09/17/14

Corporate Governance Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitle
William Keller 42 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk Committee
R. Norby 53 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Alvin Parven 10 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk Committee
Ann Veneman J.D. 52 Relationships--
ALXN and Competitor
Insiders vs. External
Board
18%
82%
Alexion Pharmaceuticals, Inc.
25%
75%
Regeneron Pharmaceuticals, Inc.
10%
90%
Sigma-Aldrich Corporation
44%
56%
Croda International plc
15%
85%
Symrise AG
13%
87%
Dr. Reddy's Laboratories Ltd.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $181.96 USD +3.09

ALXN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Croda International PLC 2,596 GBp -34.00
Dr Reddy's Laboratories Ltd 3,134 INR 0.00
Regeneron Pharmaceuticals Inc $400.12 USD +6.07
Sigma-Aldrich Corp $137.16 USD -0.01
Symrise AG €50.26 EUR -0.331
View Industry Companies
 

Industry Analysis

ALXN

Industry Average

Valuation ALXN Industry Range
Price/Earnings 79.0x
Price/Sales 18.1x
Price/Book 12.0x
Price/Cash Flow 77.5x
TEV/Sales 17.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.